T
The Oncology Institute, Inc. (TOI)
NCM – Real Time Price. Currency in USD
5.39
+0.27 (5.27%)
At close: Jun 26, 2026, 4:00 PM EDT
5.30
-0.09 (-1.67%)
After-hours: Jun 26, 2026, 6:40 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
5.39
+0.27 (5.27%)
At close: Jun 26, 2026, 4:00 PM EDT
5.30
-0.09 (-1.67%)
After-hours: Jun 26, 2026, 6:40 PM EDT
No Data
There are no news for this stock.
Total debt $104.9M significantly exceeds cash reserves ($30.3M), raising financial stability concerns
Total current assets $116.9M exceed Total current liabilities $79.4M, highlighting excellent liquidity
Debt-to-equity ratio (-6.4) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-3.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.47 | 1.59 | 7.0 | |
| Quick ratio | 1.17 | 1.27 | 7.0 | |
| Debt to Equity | N/A | 0.27 | 1.0 | |
| Debt to Assets | 0.62 | 0.72 | 3.0 | |
| Interest coverage | -3.37 | 25.51 | 1.0 | |
| Weighted average score | 3.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 252M | 324M | 393M | 503M | 546M |
| Gross Profit | 48M | 54M | 48M | 69M | 76M |
| Operating Income | -71M | -60M | -60M | -36M | -33M |
| Net Income | 132K | -68M | -53M | -50M | -36M |
| EBITDA | -67M | -54M | -54M | -29M | -26M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 31.13 | 56.67 | 10 |
| Next quarter | 24.12 | 67.86 | 10 |
| Current year | 30.24 | 72.22 | 10 |
| Next year | 25.38 | 46.67 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 3.86 | 67.42 | 66.67 | -249.87 | 6.3 |
| Y/Y | 41.22 | 86.97 | 90.48 | 38.73 | 10 |
| 3y average | 25.85 | -17164.98 | -97.1 | 24.48 | 5.5 |
| 5y average | 22.03 | -10274 | -80.63 | -1018.95 | 3.3 |
| Weighted average score | 6.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |